Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 331.00
Bid: 328.00
Ask: 333.00
Change: 10.50 (3.28%)
Spread: 5.00 (1.524%)
Open: 316.50
High: 333.00
Low: 315.00
Prev. Close: 320.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Keppler Cheuvreux raises Pearson to Hold

Thu, 30th Sep 2021 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

JPMORGAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 240 (245) PENCE - 'OVERWEIGHT'

----------

KEPLER CHEUVREUX RAISES PEARSON TO 'HOLD' (REDUCE) - PRICE TARGET 750 (670) PENCE

----------

BERENBERG RAISES PEARSON PRICE TARGET TO 590 (500) PENCE - 'SELL'

----------

GOLDMAN SACHS CUTS ROYAL MAIL PRICE TARGET TO 661 (681) PENCE - 'BUY'

----------

JEFFERIES RAISES FERGUSON PRICE TARGET TO 12,067 (11,560) PENCE - 'BUY'

----------

BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1,775 (1,800) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 397 (388) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES BUNZL PRICE TARGET TO 2,500 (2,350) PENCE - 'EQUAL WEIGHT'

----------

JEFFERIES RAISES BARCLAYS PRICE TARGET TO 315 (300) PENCE - 'BUY'

----------

FTSE 250

----------

LIBERUM CUTS SSP GROUP PRICE TARGET TO 375 (400) PENCE - 'BUY'

----------

JEFFERIES RAISES OSB GROUP PRICE TARGET TO 720 (410) PENCE - 'BUY'

----------

LIBERUM RAISES OXFORD BIOMEDICA PRICE TARGET TO 1,840 (1,560) PENCE - 'BUY'

----------

RBC RAISES 3I INFRASTRUCTURE PRICE TARGET TO 350 (325) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES TRAINLINE PRICE TARGET TO 440 (350) PENCE - 'BUY'

----------

BERENBERG RAISES WH SMITH PRICE TARGET TO 1,750 (1,500) PENCE - 'HOLD'

----------

JEFFERIES RAISES ELECTROCOMPONENTS PRICE TARGET TO 1,250 (1,230) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CREDIT SUISSE RAISES SAGA PRICE TARGET TO 471 (434) PENCE - 'OUTPERFORM'

----------

JEFFERIES CUTS BOOHOO PRICE TARGET TO 430 (500) PENCE - 'BUY'

----------

LIBERUM RAISES GEMFIELDS GROUP PRICE TARGET TO 20 (16) PENCE - 'BUY'

----------

BERENBERG RAISES DALATA HOTEL PRICE TARGET TO 410 (400) PENCE - 'BUY'

----------

JPMORGAN RAISES ABCAM PRICE TARGET TO 1,650 (1,300) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2018 10:14

First patient successfully dosed with Oxford BioMedica's OXB-102

(Sharecast News) - Gene and cell therapy group Oxford BioMedica noted on Thursday that its partner, Axovant Sciences - a company developing innovative gene therapies for neurologic and neuromuscular diseases - has announced the successful dosing of the first patient in a clinical study of AXO-Lenti-PD, also known as OXB-102.

Read more
13 Sep 2018 15:46

'Transformative year' sees Oxford Biomedica profit from two huge contracts

(Sharecast News) - Biopharmaceutical company Oxford Biomedica saw its shares rise on Thursday after its first half gross income more than doubled due to two huge contracts.

Read more
22 May 2018 16:13

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 23 MayBovis Homes GroupSt James's Place Keller GroupGamma Emerging

Read more
4 May 2018 11:57

Oxford BioMedica To Cut Share Capital Through Consolidation (ALLISS)

LONDON (Alliance News) - Oxford BioMedica PLC said Friday it is proposing reducing the issued share capital of the company by a factor of 50 through a share capital consolidation.On Oxford

Read more
15 Mar 2018 11:45

Oxford Biomedica Loss Narrows, Revenue Grows In Transformational 2017

LONDON (Alliance News) - Gene therapy firm Oxford Biomedica PLC said Thursday its 2017 loss narrowed after revenue grew significantly on product progress and finance costs in

Read more
9 Mar 2018 17:16

Oxford BioMedica To Raise GBP21 Million Via Discounted Share Issue (ALLISS)

LONDON (Alliance News) - Oxford BioMedica PLC said Friday it intends to raise GBP20.5 million via a accelerated share book build process to fund the expansion a

Read more
10 Oct 2016 14:19

Oxford BioMedica's RetinoStat achieves 'favourable safety profile' in tests

(ShareCast News) - AIM-listed pharmaceutical Oxford BioMedica's RetinoStat, the first ocular lentiviral gene therapy to be administered in humans, demonstrated a "favourable safety profile with no serious adverse events" in its phase one study. Results of the study, which were previously published i

Read more
28 Jul 2016 09:05

Oxford BioMedica Gets Approval To Manufacture Drugs At New Facilities

Read more
7 Jun 2016 06:48

Oxford BioMedica Signs New Non-Exclusive Licence Deal With MolMed

Read more
2 Jun 2016 11:03

LONDON MARKET MIDDAY: Platinum Firm Gleams Ahead Of ECB, OPEC Outcomes

Read more
2 Jun 2016 09:16

Oxford Biomedica Signs Collaboration Deal With Green Cross LabCell

Read more
31 May 2016 15:04

UK Shareholder Meetings Calendar - Next 7 Days

Read more
24 May 2016 10:42

DIRECTOR DEALINGS: Oxford BioMedica Chairman Ups Interest

Read more
6 May 2016 09:28

WINNERS & LOSERS SUMMARY: Interserve Shares Demolished By Warning

Read more
6 May 2016 07:37

Oxford Biomedica Welcomes Positive LentiVector Test Data

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.